Bogardus Medical Systems, Inc. (BMSi) recognized the complexity of building an e-prescribing system for their ONCOCHART EMR system that was compliant with the CMS incentive programs based on the AARA HITECH ACT. Instead of expending the time and efforts needed to build their own system, BMSi set out to find a qualified e-prescribing partner who excelled in three main areas: ease of use for their clients, simple interface for ONCOCHART’s development staff, and a good support reputation.
As Jeffrey Carlin, COO, BMSi/ONCOCHART explains: “We first identified three potential partners based on industry reputation and calls to existing clients. We then conducted phone interviews with each of the three, looking primarily for clues to their commitment to partner support. Based on those interviews, we picked DrFirst.” Through their partnership with DrFirst, BMSi is able to offer their current and potential clients a state-of-the-art certified product with a comprehensive e-prescribing platform.
“The partnership enabled us to certify our EMR on time and on budget. DrFirst pre-certified us with Surescripts and made the e-prescribing part of certification a complete non-issue.”
— Jeffrey Carlin, Chief Operating Officer, Bogardus Medical Systems, Inc.
In addition to including the power of the award-winning e-prescribing software in the ONCOCHART system, BMSi is also able to offer the DrFirst electronic prescribing for controlled substances (EPCS) solution, which was first to be fully compliant with all federal requirements for sending electronic prescriptions for controlled substances.
BMSi has a customer base largely comprising oncologists who write prescriptions almost exclusively for scheduled medications. Through DrFirst, BMSi is able to offer a state-of-theart certified product that fits the distinct needs of its client base, while saving substantial amounts in potential development and maintenance costs.